Alcon AG

Alcon AG

ALC · NYSE · Healthcare / Medical Instruments & Supplies

74.12USD+2.29 (+3.19%)

Price History

Full chart

Market Stats

Previous Close71.83
Open72.97
Day Range72.58 – 74.18
52-Week Range61.84 – 87.22
Volume2.78M
Market Cap33.92B
P/E (TTM)53.16
Forward P/E16.92
EPS1.32
Dividend Yield0.51%
Beta0.73
50-Day Avg67.96
200-Day Avg72.19

About

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. In addition it also develops and commercializes therapies for chronic eye diseases, focusing on encapsulated cell therapy platforms for ocular conditions. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. David J. Endicott
  • Employees25.00K
  • HeadquartersChemin de Blandonnet 8, Geneva, Switzerland, 1214, USA
  • Websitehttps://www.alcon.com

Leadership

  • Mr. David J. EndicottCEO & Director · b. 1965
  • Mr. Timothy C. StonesiferSenior VP & CFO · b. 1967
  • Mr. Ian BellSenior VP & COO · b. 1971
  • Margaret BuckleyChief Accounting Officer
  • Dr. Franck Leveiller Ph.D.SVP of Global Research & Development and Chief Scientific Officer
  • Mr. Muru MurugappanSenior VP and Chief Information & Transformation Officer
  • Mr. Royce R. Bedward J.D.Senior VP, General Counsel & Corporate Secretary · b. 1966
  • Ms. Kimberly MartinSenior VP and Chief HR & Corporate Communications · b. 1975
  • Mr. Leon Sergio Duplan FraustroSenior VP & President of Americas · b. 1968
  • Mr. Laurent AttiasSenior VP of Corporate Strategy, Business Development and Licensing (BD&L), M&A · b. 1968

Financials

Income Statement

Currency: USD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue6.52B6.60B6.79B7.15B7.51B6.83B8.29B8.72B9.46B9.91B10.40B
Growth (%)-+1.20%+2.97%+5.32%+4.96%-8.99%+21.34%+5.14%+8.47%+4.82%+4.94%
Cost of Revenue3.39B3.48B3.59B3.96B3.85B3.89B3.64B3.97B4.21B4.40B4.66B
Gross Profit3.12B3.11B3.20B3.19B3.66B2.94B4.65B4.75B5.25B5.51B5.75B
Gross Margin47.92%47.16%47.17%44.62%48.77%43.03%56.11%54.47%55.49%55.61%55.24%
Operating Expense2.72B3.10B3.28B3.44B3.85B3.42B4.07B4.08B4.21B4.10B4.38B
Operating Income401.12M10.00M-77.00M-248.00M-187.00M-482.00M580.00M672.00M1.04B1.41B1.36B
Operating Margin6.15%0.15%-1.13%-3.47%-2.49%-7.05%7.00%7.71%10.99%14.26%13.08%
EBITDA1.57B1.17B1.20B1.35B1.22B1.08B1.76B1.74B2.24B2.68B2.50B
EBITDA Margin24.04%17.70%17.73%18.85%16.23%15.81%21.21%19.96%23.71%27.00%23.99%
Net Income296.27M-170.00M256.00M-227.00M-656.00M-531.00M376.00M335.00M974.00M1.02B980.00M
Net Income Margin4.55%-2.58%3.77%-3.17%-8.74%-7.77%4.54%3.84%10.30%10.27%9.42%
R&D440.56M499.00M584.00M587.00M656.00M673.00M842.00M702.00M859.00M876.00M990.00M
R&D as % of Total Revenue6.76%7.57%8.60%8.21%8.74%9.85%10.16%8.05%9.09%8.84%9.52%
Interest Expense17.31M30.05M27.00M23.83M134.44M131.67M120.26M138.40M189.00M186.18M204.00M
Interest Expense % of Total Revenue0.27%0.46%0.40%0.33%1.79%1.93%1.45%1.59%2.00%1.88%1.96%

Balance Sheet

Currency: USD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets28.20B27.74B27.39B27.06B27.66B27.60B28.00B29.21B29.61B30.35B31.55B
Total Liabilities4.57B4.73B4.36B4.42B8.35B8.78B8.74B9.53B8.99B8.79B9.52B
Total Equity23.64B23.01B23.03B22.64B19.30B18.82B19.26B19.68B20.62B21.55B22.03B
Cash285.00M162.00M172.00M227.00M822.00M1.56B1.57B980.00M1.09B1.68B1.53B
Total Debt302.00M249.00M149.00M136.00M3.80B4.50B4.48B5.07B5.13B5.14B5.25B
Net Debt2.00M87.00M-23.00M-91.00M2.98B2.94B2.90B4.09B4.04B3.45B3.72B

Cash Flow

Currency: USD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow1.32B1.25B1.22B1.14B920.00M823.00M1.34B1.22B1.39B2.08B2.27B
Investing Cash Flow-517.51M-843.00M-679.00M-1.00B-1.01B-572.00M-1.20B-1.86B-1.09B-1.17B-1.34B
Financing Cash Flow-796.47M-435.00M-539.00M-78.00M659.00M466.00M-123.00M-8.00M-211.00M-322.00M-1.12B
Capital Expenditure485.77M506.00M496.00M712.00M676.00M567.00M1.18B745.00M851.00M670.00M663.00M
Free Cash Flow832.06M739.00M722.00M428.00M244.00M256.00M165.00M472.00M537.00M1.41B1.61B
Dividends Paid---54.00M54.00M54.00M54.00M100.00M116.00M130.00M166.00M
FCF to OCF63.14%59.36%59.28%37.54%26.52%31.11%12.27%38.78%38.69%67.74%70.81%
Dividend Paid to FCF---12.62%22.13%21.09%32.73%21.19%21.60%9.24%10.32%

Earnings

Report DateFeb 27, 2019May 15, 2019Aug 20, 2019Nov 19, 2019Feb 25, 2020May 12, 2020Aug 18, 2020Nov 10, 2020Feb 23, 2021May 4, 2021Aug 17, 2021Nov 9, 2021Feb 15, 2022May 10, 2022Aug 9, 2022Nov 15, 2022Feb 27, 2023May 9, 2023Aug 15, 2023Nov 14, 2023Feb 27, 2024May 13, 2024Aug 20, 2024Nov 12, 2024Feb 25, 2025May 13, 2025Aug 19, 2025Nov 11, 2025Mar 3, 2026May 5, 2026Aug 10, 2026Nov 10, 2026
EPS Estimate0.00-0.080.480.460.460.34-0.180.230.410.450.450.510.500.530.560.480.420.610.650.660.680.730.730.740.720.760.710.770.780.820.770.89
EPS Actual0.39-0.220.470.460.450.45-0.210.390.410.490.560.540.560.680.630.500.420.700.690.660.690.780.740.810.720.730.760.790.780.850.84-
Surprise--175.00%-2.08%0.00%-2.17%32.35%-16.67%69.57%0.00%8.89%24.44%5.88%12.00%28.30%12.50%4.17%0.00%14.75%6.15%0.00%1.47%6.85%1.37%9.46%0.00%-3.95%7.04%2.60%-0.55%3.66%9.09%-
Timing-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap33.92B
Enterprise Value36.39B
Trailing P/E53.16
Forward P/E16.92
PEG Ratio1.21
Price / Sales3.12
Price / Book1.52
EPS1.32
Book Value44.67
Revenue (TTM)10.86B
Gross Profit (TTM)6.22B
EBITDA2.40B
Profit Margin5.92%
Operating Margin14.63%
Return on Equity2.94%
Return on Assets2.80%
Shares Outstanding483.40M
Shares Float481.83M
Beta0.73
Dividend Yield0.51%
Dividend Rate0.36
Payout Ratio10.99%

Analyst Ratings

Buy
Based on 27 analystsTarget 82.73
  • Strong Buy
    17
  • Buy
    4
  • Hold
    5
  • Sell
    1

Ownership Breakdown

Institutions
63.10%
Insiders
0.20%
Retail / Other
36.70%

Top Institutional Holders

  • Vanguard Capital Management, LLC
    14.75M3.05%
  • Bank of New York Mellon Corp
    13.06M2.70%
  • NORGES BANK
    10.98M2.27%
  • Amvescap Plc.
    10.38M2.15%
  • Ako Capital Llp
    9.68M2.00%
  • Aristotle Capital Management LLC
    9.15M1.89%
  • Zurcher Kantonalbank
    7.92M1.64%
  • FMR Inc
    7.66M1.59%
  • UBS Group AG
    7.16M1.48%
  • Amundi
    6.64M1.37%
  • Select Equity Group LP
    5.77M1.19%
  • Vontobel Holding Ltd.
    5.64M1.17%
  • Pictet Asset Manangement SA
    5.53M1.14%
  • Deutsche Bank AG
    5.35M1.11%
  • The Goldman Sachs Group Inc
    4.68M0.97%
  • Vanguard Fiduciary Trust Co
    4.32M0.89%
  • Allspring Global Investments Holdings, LLC
    4.10M0.85%
  • Royal Bank of Canada
    4.02M0.83%

Top Fund Holders

  • Vanguard Total Intl Stock Index Inv
    7.20M1.49%
  • Vanguard Developed Markets Index Admiral
    4.75M0.98%

Dividends

20261×
0.36May 6, 2026
20251×
0.33May 14, 2025
20241×
0.26May 14, 2024
20231×
0.24May 10, 2023
20221×
0.20May 3, 2022
20212×
0.11May 4, 20210.10Apr 30, 2021